WASHINGTON, DC--(Marketwired - Jul 1, 2013) - King & Spalding added David J. Farber, a life sciences and healthcare regulatory litigation specialist, as a partner in its Food and Drug Administration, life sciences and healthcare practices in the firm's Washington, D.C., office. Farber was a partner at Patton Boggs.
"David is one of the top practitioners in life sciences and healthcare law, and we are delighted to welcome him to our firm," said King & Spalding FDA and life sciences practice group leader Mark S. Brown. "His regulatory experience complements our capabilities in those areas, and we believe his unique talents will be of great benefit to our clients."
Farber has a strong litigation background in the life sciences and health care sectors and is a leading national expert on Medicare secondary payor matters. His practice also encompasses government advocacy and regulatory counseling. He works regularly on Capitol Hill and with key regulatory agencies, particularly the Centers for Medicare & Medicaid Services and U.S. Food and Drug Administration on legislative and regulatory advocacy and counseling matters. Farber received a J.D. degree from Georgetown University Law Center and a B.A. degree from New York University.
Farber said: "I have been highly impressed with the reputation of King & Spalding in the FDA, life sciences and healthcare areas. The firm is uniquely positioned to service life sciences and healthcare clients at the highest levels. Its lawyers are talented and well-integrated across several areas of my practice. I am excited to be working with them to provide the high-level service our clients need and have come to expect."
King & Spalding's FDA, life sciences and healthcare practices focus on representing pharmaceutical, medical device, biotechnology and other healthcare technology companies, as well as food manufacturers, in a wide range of regulatory, compliance, policy and litigation matters, as well as healthcare companies involved in the delivery of healthcare and payment for healthcare services. The firm represents more than 100 drug and device manufacturers and others in the healthcare technology sector, including nine of the 25 largest pharmaceutical manufacturers, and 18 of the 25 largest device manufacturers. Ranked by Modern Healthcare magazine in September 2012 as the largest healthcare practice in the United States, the firm has received national acclaim for excellence in transactional, litigation and regulatory representation of healthcare clients.
About King & Spalding
Celebrating more than 125 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 800 lawyers in 17 offices in the United States, Europe, the Middle East and Asia. The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, uncompromising commitment to quality and dedication to understanding the business and culture of its clients. More information is available at www.kslaw.com.